Provincial Health Services Authority (PHSA) improves the health of British Columbians by seeking province-wide solutions to specialized health care needs in collaboration with BC health authorities and other partners.
Updated 28 July 2008
All of these must be present:
Usually the paraprotein type is IgG or IgA and the level is less than 30 g/L and the levels of the uninvolved immunoglobulins are normal, however, in up to 25% of cases of MGUS one or more of the uninvolved immunoglobulins may be below normal.
Patients with MGUS do not require any treatment, unless they develop lesions or syndromes attributable to the paraprotein, such as peripheral neuropathy, amyloidosis or renal dysfunction. It is quite rare for such complications to be seen with MGUS. Such findings usually indicate that myeloma is actually present and will eventually manifest itself.
Patients with MGUS are at risk to develop lymphoproliferative diseases such as myeloma or malignant lymphoma. They should be re-examined annually and at those times the following tests should be obtained:
BC Cancer Agency. All Rights Reserved.